How much does Trientine capsules cost? What is its market pricing?

Trientine is an oral chelator commonly used to treat Wilson's disease. It can help patients excrete excess copper ions from the body, thereby preventing organic damage caused by copper accumulation in the liver, brain and other tissues. With the widespread use of this drug in clinical treatment, the importance of trientine has gradually attracted more and more attention from patients and doctors. In recent years, trientine has been officially launched in my country, providing a new treatment path for Wilson's disease patients who need long-term medication.

At present, although trientine has been marketed in China, it has not yet been included in the national medical insurance directory. This means that patients need to pay for the drug in full out-of-pocket when using it, which imposes a relatively large financial burden. Due to differences in the procurement channels and pricing mechanisms of different hospitals or pharmacies, the retail price of trientine in China is not completely unified. It is recommended that patients go to the local hospital pharmacy or professional drug service platform for consultation before actually purchasing the drug to obtain the most accurate quotation information.

In the international market, the price of the original trientine drug cannot be ignored. It is understood that the original version of trientine capsules from Germany (specification: 200mg*100 capsules) costs about more than 40,000 yuan per box. This price is undoubtedly a heavy burden for patients with Wilson's disease who require long-term medication. Although drug subsidy policies or insurance reimbursement mechanisms exist in some foreign countries or regions, the cost is still high for patients who purchase drugs at their own expense from overseas channels.
Overall, as an important drug in the treatment of Wilson's disease, the price of trientine is generally high worldwide. Although it is currently on the market in China, it is not included in medical insurance, which still limits the accessibility of the medication to some patients. In the future, if the drug can be included in medical insurance or more affordable alternative versions can be introduced, the financial pressure on patients' families will be greatly reduced. At the same time, doctors should also fully consider the affordability of drugs when formulating treatment plans to help patients optimize their medication while ensuring the therapeutic effect.
Reference: https://www.cufence.com/